Opioid Prescribing Trends After Guidelines - Summary - MDSpire

Opioid Prescribing Trends After Guidelines

  • By

  • Kathryn Wighton

  • March 27, 2026

  • 2 min

Share

Objective:

To evaluate the impact of the 2021 clinical practice guidelines on opioid and nonopioid prescribing trends among patients undergoing parotidectomy.

Approach:
    Key Findings:
    • Opioid prescribing decreased by 7.44% immediately after guideline publication and continued to decline by 0.20% every 3 months.
    • Nonopioid prescribing increased by 3.73% immediately and continued to rise by 0.12% every 3 months.
    • 46% of patients were prescribed opioids postoperatively, while 7% received only nonopioid medications.
    Interpretation:

    The study indicates a significant shift in prescribing practices following the release of the guidelines, with a sustained reduction in opioid prescriptions and an increase in nonopioid alternatives.

    Limitations:
    • Inability to capture over-the-counter medication use.
    • Lack of data on dosage, duration, or total opioid consumption.
    • Potential bias from electronic health record coding.
    • Study design does not establish a causal relationship between guideline publication and prescribing patterns.
    Conclusion:

    An immediate and sustained reduction in opioid prescribing for parotidectomy patients was observed following the guideline publication.

    Sources:

Original Source(s)

Related Content